Investigation of 4-piperidinols as novel H3 antagonists
- Bioorg Med Chem Lett. 2010 Nov 1;20(21):6246-9. doi: 10.1016/j.bmcl.2010.08.099.
Affiliations
- 1. Athersys Inc., 3201 Carnegie Ave., Cleveland, OH 44115-2634, USA. [email protected]
PMID: 20833043
DOI: 10.1016/j.bmcl.2010.08.099
Abstract
Compounds containing a substituted 4-piperidinol core have been found to be potent antagonists of the human H(3) receptor. The compounds exhibited up to a 60-fold preference for inhibiting the human H(3) receptor over the mouse and showed a low binding affinity for the hERG channel.